INTRODUCTION
Cutaneous metastasis of internal malignancies is rare, occurring in 0.7%-9.0% of all malignancies. 1, 2 It usually indicates intralymphatic and/or intravascular tumor dissemination with a poor prognosis. The neoplasms that most often metastasize to the skin are the most frequently occurring human cancers, such as breast cancer in women and lung cancer in men. Other tumors with a high cutaneous metastatic potential include gastrointestinal tract carcinomas. 1, 2 Similarly rare, cutaneous metastases from abdominal malignancies occur in less than 4% of patients. 2, 3 Those arising from adenocarcinomas of the colon and rectum are even more rare and typically signify widespread disease with a poor prognosis. 2, 3 Cutaneous metastases of rectal cancer usually occur within the first 3 years of follow-up. 3, 4 Most cases occur late in the course of the disease, but cutaneous metastases may be the initial presentation of the internal malignancy. Rectal carcinoma metastases to the skin have no distinctive features, presenting most often as small subcutaneous or intradermal nodules that measure 1 cm to 2 cm in diameter and tend to coalesce. These nodules tend to be asymptomatic, firm, rubbery, and painless. 4, 5 Surgical intervention is not feasible, but systemic chemotherapy and radiotherapy may help control symptoms. Prognosis is poor and median survival of patients after the appearance of cutaneous metastatic lesions is reported to be approximately 3 to 18 months. 5 We present a case of metachronous skin metastasis during chemoradiation treatment in a patient with advanced rectal cancer. This case is different from others previously reported because it is an exaggerated and uncommon form of metastatic dissemination to the skin, with massive soft tissue infiltration of the perineum. We also present a comprehensive review of all reported cases of cutaneous metastasis from rectal cancer and summarize the clinical characteristics of these patients, the treatments they received, and their outcomes.
CASE REPORT
A 47-year-old man presented in December 2012 with a 10-month history of an approximately 10 cm × 15 cm mass bulging from his anus and associated severe rectal pain, weight loss of 23 kg (50 lbs), and change in bowel habits. A biopsy of the mass revealed invasive mucinous adenocarcinoma. Colonoscopy could not be performed because of the size of the rectal mass. Computed tomography scan of the chest/abdomen and pelvis demonstrated a locally invasive rectal mass, significant aortocaval and left inguinal lymphadenopathy (Figures 1 and 2) , and bibasilar tiny nodules consistent with metastatic disease. Biopsy findings of the left inguinal lymph nodes were consistent with metastatic mucinous adenocarcinoma. Given that the disease was, on the basis of the American Joint Commission on Cancer tumor-node metastasis staging system, stage IV (T4N2M1b), surgery was not feasible. The patient was referred to medical and radiation oncology for palliative chemoradiation because of his severe rectal pain.
In January 2013, a total dose of 5040 cGy was given, delivered in 28 fractions concomitant with XELOX (capecitabine plus oxaliplatin). However, intravenous chemotherapy was stopped because of significant neuropathy as well as poor patient adherence. The patient refused any further chemotherapy. Given that his K-ras gene was not mutated, cetuximab was not administered. In September 2013, the patient was reevaluated in the surgery clinic for possible palliative resection. Repeat computed tomography scans showed minimal improvement in the size of the tumor and the 
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Cutaneous Metastasis of Rectal Cancer: A Case Report and Literature Review retroperitoneal lymphadenopathy. However, in the absence of tumor-related complications, we thought that palliative surgery would be of no benefit to the patient in terms of survival and quality of life. In April 2014, the patient returned to the surgery clinic and was found to have extensive new skin lesions involving the genital area, bilateral groin, and perineum ( Figure 3 ). A biopsy of the skin lesion found metastatic moderately differentiated adenocarcinoma, most likely of rectal origin, infiltrating the skin and subcutaneous tissue. Palliative radiation therapy was initiated. The patient tolerated the additional radiation dose, and he had excellent local response to it. He is still alive more than a year after the diagnosis of skin metastasis and has not shown any disease progression.
DISCUSSION
Metastases to the skin occur in the course of malignancy, especially in extensive metastatic disease. They may represent failure of ongoing therapy or recurrence of a neoplasm thought to have been eradicated; or, they may be the first manifestation of asymptomatic, unsuspected occult malignancy. We present a case of extensive skin metastasis to the perineum in a patient with unresectable rectal cancer receiving palliative chemoradiation. To date, there has been no solid data about the incidence of cutaneous metastasis from rectal carcinoma because most of the data have been obtained from autopsy series. Reingold reviewed the autopsy findings of 32 patients with cutaneous metastasis from internal carcinoma, excluding breast cancer. 4 He found that the prevalence of cutaneous metastasis was 32 cases out of 2300 internal carcinomas studied. The most common primary site was the lung (16 cases). The rectum was the site of the primary tumor in only 1 case. The most common sites of metastasis were chest skin and abdominal skin, with rectal carcinoma cutis occurring in the right first toe, chest, and abdomen.
Lookingbill et al 2, 6 conducted two large retrospective studies at Hershey Medical Center in Pennsylvania to analyze the relative frequencies of skin metastases according to the type and location of the primary tumor and the site of the cutaneous metastases. The first study, 6 performed in 1990, reported on 7316 cancer patients, including 772 with colorectal cancer. Cutaneous involvement was present at the time of diagnosis in 4 patients (0.05% of patients with colorectal cancer); clinical information was not available for those patients, and it is not clear whether the primary cancers were rectal or colonic. The second study, 2 conducted in 1993, examined the records of 4020 patients with metastatic disease, including 420 (10%) with skin metastases. In the cohort of 413 patients with metastatic colon cancer, 18 (4.4%) had skin metastases. Eleven of the 18 had only local metastases, most of them located in the abdominal incision site.
We found 28 cases 7-27 of cutaneous metastases from rectal cancer in the English-language literature, including 2 case series comprising 6 cases each 18, 20 (Table 1 ). The mean age of patients was 55.5 years (range 29-79), 19 were men, and adenocarcinoma was the underlying histology in all. Highrisk features such as mucinous (n = 7), signet ring cell (n = 4), and poorly differentiated (n = 4) were present in 54% of patients. Most of the patients presented with advanced-stage disease (stage III in 10 patients and stage IV in 11 patients). Surgical resection, either low anterior resection or a Interval between cancer treatment/diagnosis and skin metastasis presentation. b In those patients, skin metastasis was the first sign of the underlying malignancy. Therefore, there was no interval between the primary cancer diagnosis and the onset of the skin metastasis. c Described in this article. -= data not reported; AC = adjuvant chemotherapy; ACR = adjuvant chemoradiation; APR = abdominoperineal resection; C = chemotherapy; CR = chemoradiation; F = female; LAR = low anterior resection; M = male; mets = metastasis; NCR = neoadjuvant chemoradiation; NR = neoadjuvant radiation; R = radiation; WLE = wide local excision.
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Cutaneous Metastasis of Rectal Cancer: A Case Report and Literature Review abdominoperineal resection, was performed in 16 patients, with chemoradiation given either preoperatively or postoperatively. Skin metastasis presented as a recurrence in 20 patients, with an average time to recurrence of 18 months (range 1-42). Skin metastasis was the first sign of the underlying malignancy in the remaining 8 patients. The perineum was the site of the skin metastases in 11 patients. Among the rest, skin metastases occurred at multiple sites, with frequent involvement of the chest and axillae. The face and extremities were infrequently involved. Among reports describing morphology, skin nodules were most common. Most patients (20/28) received treatment for skin metastasis: excision with or without chemoradiation (n = 8), chemotherapy and/or radiation therapy alone (n = 11), or abdominoperineal resection (n = 1). Vital status was reported for 20 patients. Among these, 15 died. The duration of follow-up was reported for only 19 patients. The average time from skin metastasis diagnosis to death was about 10 months (median 4, range 1-56).
Although cutaneous metastasis typically signifies widespread disease and a poor prognosis, several cases of isolated rectal metastases to the skin without evidence of visceral disease have been reported. 7, 9, 11, 13, [15] [16] [17] 26, 27 Also, in a minority of patients, cutaneous disease may precede metastasis to other organs. 14, 18, 19 In these cases, it is imperative that the skin lesion be detected early, biopsied, and properly diagnosed. Alternately, skin metastasis could be the first sign of an underlying advanced rectal cancer. 20, 23 Gazoni et al 20 reported a series of 6 patients with concurrent diagnoses of advanced stage IV rectal cancer and skin metastases. None survived more than 7 months after diagnosis, regardless of the treatment modality. 20 Therefore, recognition of suspicious skin lesions as possible harbingers of undiagnosed visceral malignancy is important in treating patients with or without a history of cancer.
Several mechanisms of cutaneous metastasis have been postulated. Kauffman and Sina 10 suggested that metastatic spread of adenocarcinoma to the skin and subcutaneous tissue could be caused by lymphatic and hematogenous spread, direct extension, or implantation during surgery. They reported a case of adenocarcinoma of the rectum with inflammatory metastases to skin on the thigh. They were able to show through immunohistochemical evaluation that the dermal vessels containing neoplastic cells were both lymphatic and capillary vessels and thus concluded that the tumor cells travelled to the skin via lymphatics and blood vessels. All three mechanisms of metastasis occurred in our patient. Considering that skin metastases developed close to the primary cancer in a setting of heavy nodal disease, the likely pathophysiology is a combination of intravascular and lymphatic dissemination. However, the possibility of implantation during the biopsy of the left inguinal lymph nodes cannot be excluded.
CONCLUSION
Cutaneous metastases are a rare and usually signify disseminated disease. Their presence warrants a thorough metastatic workup. Clinicians treating patients with internal carcinomas should look for skin involvement even after a long asymptomatic period, paying special attention to all skin nodules, nonhealing ulcers, and persistent indurate erythema. Early detection and recognition of metastatic disease in the skin can dramatically alter treatment and prognosis. A high index of suspicion is recommended when new skin lesions are found in cancer patients. Patient education plays a major role in this early detection. Patients with a history of rectal carcinoma should be taught to inspect all areas of their skin several times annually, to recognize the signs of cutaneous metastases, and to take appropriate action if they find a questionable lesion. It is extremely important that patients with cancer receive regular dermatologic examinations and that practitioners remain aware of the potential for metastasis to the skin. v
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